Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peroxisome proliferator-activated receptors (PPARs) are a group of nuclear receptor proteins that function as ligand-activated transcription factors. They play crucial roles in the regulation of cellular differentiation, development, metabolism (particularly lipid and glucose metabolism), and tumorigenesis in higher organisms. There are three main isoforms: PPARα, PPARγ, and PPARβ/δ, each with distinct tissue distribution, physiological functions, and ligand specificities. Upon activation, PPARs regulate gene transcription by binding to PPREs in the promoter regions of target genes.
Upon activation by ligands, PPARs heterodimerize with RXR and bind to PPREs in the promoter regions of target genes, modulating gene transcription through recruitment of coactivators or corepressors.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peroxisome Proliferator-Activated Receptor (PPAR).